Humana (NYSE:HUM) Sets New 52-Week High Following Analyst Upgrade

Humana Inc. (NYSE:HUM – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Friday after Wolfe Research upgraded the stock from a hold rating to a strong-buy rating. The company traded as high as $351.88 and last traded at $345.6940, with a volume of 621921 shares changing hands. The stock had previously closed at $349.80.

A number of other equities research analysts also recently issued reports on HUM. Oppenheimer upgraded shares of Humana from an “outperform” rating to an “outperform” rating in a report on Wednesday, May 20th. Seaport Research Partners downgraded shares of Humana to a “neutral” rating in a report on Wednesday, May 20th. Robert W. Baird lowered their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. UBS Group boosted their target price on shares of Humana from $262.00 to $320.00 and gave the company a “neutral” rating in a report on Friday, May 22nd. Finally, Jefferies Financial Group upgraded shares of Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, fourteen have issued a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $279.30.

Get Humana alerts:

Get Our Latest Research Report on Humana

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Revolve Wealth Partners LLC acquired a new stake in Humana in the fourth quarter valued at $202,000. Woodline Partners LP raised its holdings in Humana by 460.0% in the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after acquiring an additional 8,372 shares in the last quarter. Sivia Capital Partners LLC raised its holdings in Humana by 53.7% in the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after acquiring an additional 452 shares in the last quarter. Cresset Asset Management LLC raised its holdings in Humana by 10.3% in the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after acquiring an additional 222 shares in the last quarter. Finally, WINTON GROUP Ltd raised its holdings in Humana by 58.5% in the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after acquiring an additional 879 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Down 1.2%

The stock has a market capitalization of $41.48 billion, a price-to-earnings ratio of 36.98, a PEG ratio of 1.87 and a beta of 0.76. The firm’s fifty day moving average is $244.92 and its 200-day moving average is $231.58. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s quarterly revenue was up 23.5% on a year-over-year basis. During the same period in the prior year, the company posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, sell-side analysts predict that Humana Inc. will post 9 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.0%. Humana’s payout ratio is presently 37.86%.

About Humana

(Get Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Featured Stories

• Five stocks we like better than Humana
• Navitas: NVIDIA’s AI Power Broker?
• A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
• NVIDIA’s New Power Play: Why Fluence Is Surging
• Broadcom’s Whiplash: Shares Tank After Pre-Earnings Surge

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.